The report calls on the FDA to move beyond its standard matrix of considerations for drug safety, David Clark says.http://stanford.io/2uBdlq7
0 replies
10 retweets
15 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.